Algemeen nieuws

Angela Maas nieuw lid Raad van Toezicht UMC Utrecht

Karin Jongsma benoemd tot hoogleraar

Baby’s beter beschermen tegen RSV

Landelijke aanpak voor opsporen erfelijke borstkanker

Eerste CAR-T-therapie bij systemische sclerose in UMC Utrecht

Preventie werkt, ook bij chronisch zieke kinderen

Waarom mensen met diabetes type 2 meer kans hebben op dementie

Sneltesten alléén verlagen antibioticagebruik voor luchtweginfecties niet

Zulke testen zijn alleen effectief als ze onderdeel zijn van een bredere aanpak

Darmkanker herprogrammeren: team REWIRE-CAN

Kleine patiënten en slimme oplossingen in het WKZ

Baby's in het WKZ krijgen sneller en relaxter een MRI.

UMC Utrecht versnelt duurzame zorg in regionale samenwerking

Waarom vroege opsporing darmkanker belangrijk is

In darmkankermaand vraagt het UMC Utrecht extra aandacht voor het belang van vroege opsporing door deelname aan het Bevolkingsonderzoek.

Vici-beurs voor onderzoek naar hersenaneurysma’s

Rechtvaardigheid als uitgangspunt voor medisch onderzoek

Rieke van der Graaf benoemd tot hoogleraar.

Voorzitter Raad van Bestuur Carina Hilders vertrekt bij UMC Utrecht

Carina Hilders vertrekt per 24 februari 2026.

Interview met 500e promovendus van het Hersencentrum

Interview met Rianne de Jongh, de 500e promovendus van het Hersencentrum.

Geen verband tussen dieet van de moeder tijdens borstvoeding en eczeem of voedselallergie bij baby’s

Jim van Os pleit in Nature voor afscheid van DSM

KGW viert lustrum met vernieuwd curriculum 

Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Assumption about cause DNA damage debunked

Worldwide, many supplements containing antioxidants, such as vitamins C and E, are being sold. These supplements would prevent cancer and ageing. New research from UMC Utrecht calls the rationale behind the protective role of antioxidants into question, putting the use of supplements with high doses of antioxidants in a different light.

European study to integrate palliative care in heart failure

Led by UMC Utrecht, a study on improving palliative care in heart failure has begun. The aim of the study is to integrate a palliative care approach into standard care for patients with heart failure and their loved ones in Europe. By responding faster and better to all the care needs of each individual patient, patients' quality of life will improve. Nine European countries are participating in the study, and the study will run for five years.

Gönül Dilaver appointed professor of Inclusive Higher Education

Dr. Gönül Dilaver, currently Biomedical Sciences program director at UMC Utrecht, has been appointed professor of Inclusive Higher Education. This appointment, effective April 1, 2024, marks an important moment in efforts to make education at Utrecht University and UMC Utrecht more accessible and inclusive. Over the years, Dilaver has championed the connection between science, society and inclusion in higher education.

Sabine Fuchs appointed professor

How do we improve care for patients with rare diseases for which there are currently no treatments? This question is central to the work of pediatrician Sabine Fuchs. She has been appointed professor of Metabolic diseases and innovative therapies at the UMC Utrecht as of April 15, 2024. ‘I want to make these types of diseases treatable by also focusing on the other organs.’

"The Next Step"... Jeanette Leusen's inaugural lecture

On Tuesday, April 9, 2024, Jeanette Leusen, professor of Antibody Therapy at Utrecht University and UMC Utrecht, delivered her inaugural lecture. There she addressed the discovery, development and clinical application of antibodies. Partly due to the research of Jeanette and her group, antibodies based on immunoglobulin A (IgA) also appear to have great potential as a next generation treatment option in cancer, and perhaps also in infectious diseases. A first drug candidate is now ready for the next step: a ‘first-in-human’ study, but this will require more investment.

Can Jos Malda crack the code of cartilage?

In our aging society, healing joint problems is becoming increasingly important. To do this, cartilage damage must become repairable. But so far it has proven impossible to recreate the intricate internal structure of cartilage. Professor Jos Malda has now received an ERC Advanced grant of €2.5 million to crack that code.

Decoding the brain - Loss of use does not mean loss of function

Imagine you are completely immobile, only able to blink to communicate with the outside world. This is the reality for people with locked-in syndrome, a condition where patients are completely paralysed except for their eyes, while being fully conscious. Mark Bruurmijn spent his PhD working on building a brain-computer interface, helping these patients to communicate. On April 11th Bruurmijn receives his doctorate for his work on decoding the brain.

"I'm a real tech guy"

How do diseases develop? How can we recognize them more quickly? And how can we treat them in a more targeted way? By analyzing very large amounts of molecular data with the latest developments in artificial intelligence (AI). This is what Jeroen de Ridder is dedicated to. As of 1 April 2024, he has been appointed as professor of bioinformatics in molecular biology at UMC Utrecht, within the Strategic Program Cancer.

Grant for research teams UMC Utrecht from ZonMw Open Competition

Five research teams of the UMC Utrecht receive a grant for projects in the framework of the ZonMw Open Competition. With this funding, the research teams can develop innovative team science initiatives that contribute to innovation within fundamental (bio)medical science and long-term health care. Within all projects, the research teams collaborate with other knowledge institutions. A total of 29 projects were honored for an amount of 23 million euros.